Press release
Top Key Players Operating in the Global NK Cells Market are Altor Bioscience Corporation, Innate Pharma, Takeda Pharmaceuticals (formerly Nycomed), Sorrento Therapeutics, Inc., NantKwest
Download report sample at: https://www.psmarketresearch.com/market-analysis/nk-cell-therapeutics-market/report-sample
The pipeline of NK cell therapeutics market is rich with more than 30 drugs. The pharmaceutical companies are actively involved in the research and development of drug for NK cells. Kyowa Hakko Kirin Co., Ltd. has Mogamulizumab drug in its Phase III clinical trial for NK cells therapeutics. Increasing use of combination therapy of NK cells is also a potential growth driver for the growth of the global market. Use of NK cells with Chimeric Antigen Receptor (CAR) T-Cell therapy helps to enhance the efficacy of the medication.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=nk-cell-therapeutics-market
NK cells are granular lymphocytes that provide innate immunity and first line of defense against viral infections and cancer. Natural killer cells are made up of 5–15% circulating lymphocytes. It is found in peripheral tissues including liver, peritoneal cavity, and placenta. NK cell are activated by interleukins that is capable of extravasations and infiltration into tissues.
However, certain factors such as side effects of NK cell medication, complex pathophysiology, and high treatment cost of NK cells are expected to hamper the growth of the global market during the forecast period.
Browse report at: https://www.psmarketresearch.com/market-analysis/nk-cell-therapeutics-market
Some of the key players operating in the global NK cells market are Chipscreen Biosciences, Ltd. Affimed N.V., Altor BioScience Corporation, Innate Pharma S.A., Takeda Pharmaceutical Company Limited, Sorrento Therapeutics Inc., NantKwest Inc., Bristol-Myers Squibb, and NKT Therapeutics, Inc.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Key Players Operating in the Global NK Cells Market are Altor Bioscience Corporation, Innate Pharma, Takeda Pharmaceuticals (formerly Nycomed), Sorrento Therapeutics, Inc., NantKwest here
News-ID: 1607122 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for Altor
Acute Lung Injury Market Size, Growing Demand to 2033 CompleGen, Altor BioScienc …
Acute Lung Injury (ALI) is a condition characterized by rapid onset of respiratory distress and impaired gas exchange, often resulting from direct or indirect injury to the lungs. It is a part of the spectrum of Acute Respiratory Distress Syndrome (ARDS), with ALI being less severe in terms of oxygenation impairment. The causes of ALI are diverse and include trauma, pneumonia, aspiration, sepsis, and inhalation of toxic substances. The hallmark…
Immune Cell Therapy Market Booming Worldwide from 2023 to 2030 |Adaptimmune, Alt …
The Immune Cell Therapy Market Trends Overview 2023-2030:
A new Report by Worldwide Market Reports, titled "Immune Cell Therapy Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," offers a comprehensive analysis of the industry, which comprises insights on the Immune Cell Therapy market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts,…
Acute Lung Injury Market Report- Size, Share, Trends, Segmentation & Forecast | …
The Acute Lung Injury Market research report gives a 360-degree perspective by looking at political, social, money-related, and innovative progressions boosting the market development. Acute Lung Injury Market also covers the rising assessment of market development and provides comprehensive information about all changes and dangers identified with the worldwide Acute Lung Injury Market during the projected period. In addition, the Acute Lung Injury Market research report covers every…
Cancer Gene Therapy Market Scope Assessment 2025 | Altor Bioscience Corporation, …
Global Cancer Gene Therapy Market: Snapshot
Gene therapy is a massive and swiftly expanding field that could hold promising cures and treatments for several diseases and genetic problems. One of the more innovative segments in gene therapy falls under cancer treatment. It is one of the widely researched aspects of gene therapy, and thanks to increasing interest and investments from both government and private organizations, is showing a swift rate of…
Cancer Gene Therapy Market Forecast and Regional Analysis by 2025 | Altor Biosci …
Global Cancer Gene Therapy Market: Overview
Cancer results from the multiple mutations in a single cell that makes it to proliferate out of control. Cancer cells invade new cellular territories, have a high metabolic rate, and an altered shape. The various methods to treat cancers are surgery, radiation, and chemotherapy. When the aforementioned therapies fail to achieve desired results, gene therapy is leveraged. Gene therapy involves the insertion of a…
Cancer Gene Therapy Market | Altor Bioscience Corporation, SiBiono., Shanghai Su …
Global Cancer Gene Therapy Market: Overview
Cancer results from the multiple mutations in a single cell that makes it to proliferate out of control. Cancer cells invade new cellular territories, have a high metabolic rate, and an altered shape. The various methods to treat cancers are surgery, radiation, and chemotherapy. When the aforementioned therapies fail to achieve desired results, gene therapy is leveraged. Gene therapy involves the insertion of a…
